1347631

Irinotecan Related Compound B

United States Pharmacopeia (USP) Reference Standard

• 別名: (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione
• 実験式（ヒル表記法）: C₂₂H₂₀N₂O₅
• CAS番号: 86639-52-3
• 分子量: 392.40
• MDL番号: MFCD00871873
• UNSPSCコード: 41116107
• PubChem Substance ID: 329750188
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: irinotecan
• メーカー／製品名: USP
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@@](O)(CC)C(=O)OC4
• InChI: 1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1
• InChI Key: FJHBVJOVLFPMQE-QFIPXVFZSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Irinotecan Related Compound B USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Irinotecan Hydrochloride

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07
• シグナルワード: Danger
• 危険有害性情報: H302,H360D,H372
• 注意書き: P202 - P260 - P264 - P270 - P301 + P312 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Oral - Repr. 1B - STOT RE 1
• ターゲットの組織: Gastro-intestinal system
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable